Preparing your plan for the GLP

Preparing your plan for the GLP-1 era After revolutionizing care for diabetes and weight loss, GLP-1 drugs are being eyed for more. Can we afford it? July 11, 2024 | 5-minute read
With more drugs and expanded indications on the way, pharmacy benefit providers need a defined strategy to manage these expensive GLP-1 agonists.
Obesity as a Chronic Disease

Though GLP-1 receptor agonists have existed for two decades, newer, more effective versions have transformed obesity care within just a few years—enabling 15 to 20 percent weight loss compared to the 5 percent with earlier generations. Yet with the swiftness of these therapies' arrival, most physicians lack access to evidence-based training on how to prescribe them effectively and safely ...
What self-funded employers should know As the GLP-1 space continues to evolve and per-prescription prices come down, overall plan costs can still go up.

Information for Part D Plans
FAQs for Part D Plans GENERAL What is the Medicare GLP-1 Bridge? The Medicare GLP-1 Bridge is a short-term demonstration run by CMS that will provide eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs between July 1 , 2026, and December 31, 2027.
The Centers for Medicare & Medicaid Services (CMS) is expanding access to certain GLP-1 medications for people with Medicare Part D through the Medicare GLP-1 Bridge short-term demonstration starting July 1 , 2026. Medicare GLP-1 Bridge will operate outside of Medicare Part D plan coverage and use a central processor to manage prior authorization, claims processing, and pharmacy payment. The ...

How health systems are preparing for Medicare's GLP
Health systems preparing Medicare GLP-1 Bridge program focus on staff education, prior authorization, and workflow coordination ahead of July 1 launch.
Medicare weight loss coverage 2026, CMS BALANCE model, $50 GLP-1 copay, Medicare GLP-1 Wegovy eligibility, Part D out of pocket cap 2026.

The GLP
The GLP-1 moment signals how quickly a high-demand therapy can upend established care patterns—and how similar innovations may emerge in the years ahead.






Learn how the Medicare GLP-1 Bridge works for prescribers—clinical criteria, prior authorization steps, and covered drugs. Starts July 1 , 2026.